Gene · 1048
Papers3,868
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,868
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated single-cell and spatial transcriptomics reveal the differentiation drivers of gastric epithelial lineage progression. | Front Immunol | 2026 | 41737224 | PubTator, text mining | PubMed |
| T cell-inspired therapeutic delivery platforms: From nanomedicines to cell therapy. | Mater Today Bio | 2026 | 41732384 | PubTator, text mining | PubMed |
| The role of antibody-drug conjugates in the treatment of lung cancer. | Front Oncol | 2026 | 41727667 | PubTator, text mining | PubMed |
| A gastric and pleural metastasis of occult breast lobular cancer in an elderly female and radiomics assisted analysis of a rare metastasis. | Front Oncol | 2026 | 41727659 | PubTator, text mining | PubMed |
| CA-CAE: A deep learning-based multi-omics model for pan-cancer subtype classification and prognosis prediction. | PLoS Comput Biol | 2026 | 41719374 | PubTator, text mining | PubMed |
| Lactylation in colorectal cancer: Unveiling novel mechanisms in metabolism, progression and therapeutic targeting. | Clin Transl Med | 2026 | 41711048 | PubTator, text mining | PubMed |
| A Network-Based Association of IBD and Colorectal Cancer Using Proteomics Data. | Proteomics Clin Appl | 2026 | 41704020 | PubTator, text mining | PubMed |
| Multiomics assessment of lung adenocarcinoma subtypes defined through tumor purity-adjusted DNA methylation. | Genome Med | 2026 | 41691315 | PubTator, text mining | PubMed |
| Spatial Analysis of Intraductal Papillary Mucinous Neoplasms Defines a Paradoxical Keratin 17-Positive, Low-Grade Epithelial Population Harboring Malignant Features. | Cell Mol Gastroenterol Hepatol | 2026 | 41638478 | PubTator, text mining | PubMed |
| Discovery and preclinical evaluation of monoclonal antibodies and bispecific engagers targeting the NKG2A inhibitory receptor. | Sci Adv | 2026 | 41637511 | PubTator, text mining | PubMed |
| Bispecific Antibodies in Breast Cancer Immunotherapy: Mechanisms, Advances, and Translational Challenges. | Target Oncol | 2026 | 41637006 | PubTator, text mining | PubMed |
| High resolution genome-wide SNP array analyses on matched colorectal-based lung and brain metastases. | J Cancer Res Clin Oncol | 2026 | 41615482 | PubTator, text mining | PubMed |
| Liquid biopsy biomarkers for accurate detection of malignant pulmonary nodules: a meta-analytic approach. | Discov Oncol | 2026 | 41612093 | PubTator, text mining | PubMed |
| Novel Drug-Disease Modeling Framework for Oncology Benefit-Risk Evaluation: Application to Tusamitamab Ravtansine. | CPT Pharmacometrics Syst Pharmacol | 2026 | 41607358 | PubTator, text mining | PubMed |
| Protumorigenic Responses of CEACAM6 in Helicobacter pylori-Infected Gastric Cancer Cells. | J Cell Mol Med | 2026 | 41603382 | PubTator, text mining | PubMed |
| The Landscape of CEACAM5 Expression by Immunohistochemistry in NSCLC. | JTO Clin Res Rep | 2026 | 41584721 | PubTator, text mining | PubMed |
| Global advances and future directions in lung cancer care: expert consensus and strategic priorities. | ESMO Open | 2026 | 41579430 | PubTator, text mining | PubMed |
| Enzymatic Remodelling of Tumour Microenvironment Enhances Anti-CEACAM5 CAR T-Cell Efficacy Against Colorectal Cancer. | Adv Sci (Weinh) | 2026 | 41572139 | PubTator, text mining | PubMed |
| A clinical-molecular nomogram for predicting early recurrence following resection of initially unresectable colorectal liver metastases. | Ther Adv Med Oncol | 2026 | 41567811 | PubTator, text mining | PubMed |
| Exploring phenotype-related single-cells through attention-enhanced representation learning. | Genome Med | 2026 | 41566378 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1048/papers?page=4